TrialInternal medicine (Tokyo, Japan)2018

A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma.

Masaki Ri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.